WHERE DOES THE MONEY GO?

Our mission?

To fund Australia’s brightest and most innovative medical researchers... 

Our aspiration?

To ensure personalised treatment for ALL new cancer patients... 

What is 'personalised' or 'precision' medicine?

Every cancer is different for every body. Precision Medicine...

Here are the incredible cancer vanquishing projects we support. 

Artboard 1 copy2.png

THE CONNIE JOHNSON BREAST CANCER RESEARCH LABORATORY

doante copy 23.png

INSTITUTE:

The Garvan Institute of Medical Research

 

CHIEF RESEARCHERS: 

Assoc. Prof. Elgene Lim & Assoc. Prof. Alex Swarbrick

 

DATE: 

2013 - extant

The Connie Johnson Laboratory performs clinically focused laboratory research, aiming to better understand the heterogeneity in breast cancer, and identifying novel ways to treat breast cancer.

Patients are key partners in this endeavour, and Assoc. Prof. Elgene Lim and Assoc. Prof. Alex Swarbrick engage patients to donate a sample of their tumour tissue to be used for research. The grant is directed, in the first instance, toward establishing the necessary infrastructure to maximise patient-centric research, broadly called Project SHARE (Specimens Help All Research Efforts). The grant will also be used to expand the Cancer Sampling Program for autopsies on patients who have died from advanced breast, prostate, lung and pancreatic cancers. Finally, the grant will establish Clinical Trials Connect, a digital platform to help cancer patients navigate current clinical trials and to connect patients with researchers.

Artboard 1 copy2.png
Macquarie University

2020 - 2025

SHARE, COLLABORATE & CURE: THE MACQUARIE UNIVERSITY CANCER BIOBANK

 

INSTITUTION:

Macquarie University

Macquarie University
Macquarie University

CHIEF RESEARCHER:

Dr. Helen Rizos

SYNOPSIS:

A bold plan to provide a library of viable cancer specimens and genomic data across many cancer types.

Olivia Newton-John Cancer Research Institute (ONJCRI) & La Trobe University

2020 - 2023

CURING THE INCURABLE: PATIENT-CENTRED DIAGNOSTICS GUIDING THE SELECTION OF THERAPIES FOR METASTATIC BREAST CANCER

 

INSTITUTION:

Olivia Newton-John Cancer Research Institute (ONJCRI) & La Trobe University

Olivia Newton-John Cancer Research Institute (ONJCRI) & La Trobe University
Olivia Newton-John Cancer Research Institute (ONJCRI) & La Trobe University

CHIEF RESEARCHER:

Dr Belinda Yeo and Dr Delphine Merino

SYNOPSIS:

A formal translational study to demonstrate the value of analysing patient samples in both early stage and advanced breast cancer, ...

Queensland Institute of Medical Research Berghofer

2021 - 2023

A NEW IMMUNOTHERAPY APPROACH TO TARGET TRIPLE-NEGATIVE BREAST CANCER

 

INSTITUTION:

Queensland Institute of Medical Research Berghofer

Queensland Institute of Medical Research Berghofer
Queensland Institute of Medical Research Berghofer

CHIEF RESEARCHER:

Prof. Kum Kum Khanna

SYNOPSIS:

This research will improve our knowledge about the factors that inhibit growth and recurrence of breast cancer, which is critical to unlocking better treatment strategies. ...

An initiative of Children’s Cancer Institute and Kids Cancer Centre at Sydney Children’s Hospital, Randwick

2021 - extant

THE ZERO CHILDHOOD CANCER PROGRAM

 

INSTITUTION:

An initiative of Children’s Cancer Institute and Kids Cancer Centre at Sydney Children’s Hospital, Randwick

An initiative of Children’s Cancer Institute and Kids Cancer Centre at Sydney Children’s Hospital, Randwick
An initiative of Children’s Cancer Institute and Kids Cancer Centre at Sydney Children’s Hospital, Randwick

CHIEF RESEARCHER:

Prof. Glenn Marshall AM

SYNOPSIS:

The Zero Childhood Cancer program aims to one day be able to provide a personalised treatment plan for every child.

The Garvan Institute of Medical Research

2021 - 2023

FINDING TREATMENT FOR RIBOCICLIB RESISTANT BREAST CANCER USING PERSONALISED MEDICINE AND BIOSENSOR TECHNOLOGY

 

INSTITUTION:

The Garvan Institute of Medical Research

The Garvan Institute of Medical Research
The Garvan Institute of Medical Research

CHIEF RESEARCHER:

Prof. Paul Timpson

SYNOPSIS:

Our ultimate goal is to have the design of an early phase clinical trial conceptually established and pre-clinically validated within the duration of this grant.

The Garvan Institute of Medical Research

2021 - 2023

PRECISION TARGETING OF BREAST CANCER FIBROSIS TO BOOST EFFICIENCY OF CHEMOTHERAPY

 

INSTITUTION:

The Garvan Institute of Medical Research

The Garvan Institute of Medical Research
The Garvan Institute of Medical Research

CHIEF RESEARCHER:

Dr. Thomas Cox

SYNOPSIS:

Dr Cox and his team have generated exciting data to identify a critical enzyme (Peroxidasin) which is involved in the formation of the scar-like matrix in breast cancer.

The University of Melbourne/Peter MacCallum Cancer Centre

2021 - 2023

MORE PRECISE RISK ESTIMATES FOR EARLY-STAGE BREAST CANCER

 

INSTITUTION:

The University of Melbourne/Peter MacCallum Cancer Centre

The University of Melbourne/Peter MacCallum Cancer Centre
The University of Melbourne/Peter MacCallum Cancer Centre

CHIEF RESEARCHER:

Dr. Peter Savas

SYNOPSIS:

This research will study how different changes in the DNA in the tumours of over 11,000 patients affect the chance of the cancer coming back after surgery.

Olivia Newton-John Cancer Research Institute (ONJCRI) & La Trobe University

2021 - 2023

IDENTIFYING TARGETS ON MYELOID CELLS TO DESIGN PERSONALISED COMBINATION IMMUNOTHERAPIES FOR TRIPLE-NEGATIVE BREAST CANCER

 

INSTITUTION:

Olivia Newton-John Cancer Research Institute (ONJCRI) & La Trobe University

Olivia Newton-John Cancer Research Institute (ONJCRI) & La Trobe University
Olivia Newton-John Cancer Research Institute (ONJCRI) & La Trobe University

CHIEF RESEARCHER:

Prof. Robin Anderson

SYNOPSIS:

Targeting pro-tumour immune cells to improve response to immunotherapy for triple-negative breast cancer patients.

Olivia Newton-John Cancer Research Institute (ONJCRI)

2019 - 2022

FULL-TIME RESEARCH ASSISTANT FOR A THREE-YEAR PERSONALISED BREAST CANCER RESEARCH PROJECT

 

INSTITUTION:

Olivia Newton-John Cancer Research Institute (ONJCRI)

Olivia Newton-John Cancer Research Institute (ONJCRI)
Olivia Newton-John Cancer Research Institute (ONJCRI)

CHIEF RESEARCHER:

Prof. Robin Anderson

SYNOPSIS:

A model to create a living breast cancer biobank.

Peter MacCallum Cancer Centre

2020 - 2023

USING POLYGENIC RISK MODIFICATION TO IMPROVE BREAST CANCER PREVENTION: THE PRIMO TRIAL.

 

INSTITUTION:

Peter MacCallum Cancer Centre

Peter MacCallum Cancer Centre
Peter MacCallum Cancer Centre

CHIEF RESEARCHER:

A/Prof. Paul James

SYNOPSIS:

Genomic testing will be used to identify women who can benefit the most from preventative strategies. Outcomes from this study will lead to the implementation of personalised risk management.

Monash University

2020 - 2023

OVERCOMING NETWORK REMODELLING TO IDENTIFY NEW THERAPEUTIC STRATEGIES FOR POOR PROGNOSIS BREAST CANCER

 

INSTITUTION:

Monash University

Monash University
Monash University

CHIEF RESEARCHER:

Dr. Lan Nguyen

SYNOPSIS:

The study will employ the use of novel machine learning techniques (data science) to develop predictive markers...

Monash University

2019 - 2020

DEVELOPING PERSONALISED TREATMENTS FOR BREAST CANCERS WITH POOR PROGNOSIS

 

INSTITUTION:

Monash University

Monash University
Monash University

CHIEF RESEARCHER:

Prof. Roger Daly

SYNOPSIS:

A comprehensive evaluation of the TAOK2 protein and its role in aggressive breast cancer.

The University of Sydney

2019 - 2020

STOPPING CANCER CELLS’ PRO-SURVIVAL MECHANISMS IN TRIPLE-NEGATIVE BREAST CANCER

 

INSTITUTION:

The University of Sydney

The University of Sydney
The University of Sydney

CHIEF RESEARCHER:

Dr. Sumit Sahni

SYNOPSIS:

Development of novel therapy targeting autophagy against Triple-Negative Breast Cancers (TNBCs).

Olivia Newton-John Cancer Research Institute (ONJCRI)

2019 - 2021

COMBATING AGGRESSIVE BREAST CANCER WITH A NEW TREATMENT

 

INSTITUTION:

Olivia Newton-John Cancer Research Institute (ONJCRI)

Olivia Newton-John Cancer Research Institute (ONJCRI)
Olivia Newton-John Cancer Research Institute (ONJCRI)

CHIEF RESEARCHER:

Prof. Matthias Ernst

SYNOPSIS:

Targeting Interleukin-11-signalling for treatment of Metastatic Breast Cancer.